Related Experiment Videos
Abstract:
Infection by spirochete Borrelia burgdorferi is mainly observed in the United States where it has taken the name of Lyme's disease, and in Europe. Its evolution may be very extended, in several phases. A few weeks after a tick-bite, the primary lesion appears, which is a chronic migrating erythema. In the following weeks or months, in the secondary phase, nerve lesions may appear, quite similar in Europe and in the United States, and cardiac lesions, mostly seen in the United States. In the following weeks, months, or years, during the tertiary phase, articular lesions may appear, frequent in the United States, much more unusual in Europe. Several years later, chronic lesions of the central nervous system may appear, described in the United States, and chronic skin lesions such as chronic atrophying acrodermatitis sometimes associated with destructive lesions of the joints underlying the skin lesion, which are only recognized in Europe. The discovery of the spirochete in a small number of these lesions, including the latest in the evolution, permits to think that, throughout this evolution, this disease is secondary to the persistence of the germ within the body; this explains the efficacy of the penicillin treatment, including in the oldest forms of the disease. Serology is quite reliable; but it becomes positive only 2 to 4 weeks after the onset of the chronic migrating erythema: needless to say the importance of this single cutaneous lesion which enables to make the diagnosis and requires the use of a tetracycline or penicillin treatment.
Insights
Borrelia burgdorferi infection, or Lyme disease, progresses through distinct phases, potentially causing various neurological, cardiac, and skin lesions. Early diagnosis via the characteristic skin lesion is crucial for effective penicillin or tetracycline treatment, even in late stages.
Area of Science:
- Infectious Diseases
- Dermatology
- Neurology
Background:
- Lyme disease, caused by the spirochete Borrelia burgdorferi, is prevalent in the US and Europe.
- The infection evolves through distinct phases, manifesting with varied symptoms over time.
- Geographical variations exist in the presentation of later-stage Lyme disease.
Purpose of the Study:
- To describe the phased evolution of Borrelia burgdorferi infection.
- To highlight the diagnostic significance of early cutaneous manifestations.
- To emphasize the role of persistent infection in disease progression and treatment efficacy.
Main Methods:
- Clinical observation of disease progression and lesion development.
- Identification of Borrelia burgdorferi in various disease stages.
- Review of treatment outcomes with antibiotics.
Main Results:
- Early phase: chronic migrating erythema (primary lesion).
- Secondary phase: neurological and cardiac lesions (cardiac more common in US).
- Tertiary/Late phases: joint, central nervous system, and chronic skin lesions (acrodermatitis) with regional variations.
Conclusions:
- Borrelia burgdorferi persistence is implicated in the long-term evolution of Lyme disease.
- Early diagnosis, particularly of the erythema migrans, is key for timely antibiotic intervention.
- Penicillin and tetracycline treatments remain effective, even for chronic and late-stage Lyme disease manifestations.